A herbal medicine for the treatment of lung cancer

Molecular and Cellular Biochemistry

Volumn 280, Issue 1-2, 2005, Pages 125-133

  Ranga, Rama S ^a   Sowmyalakshmi, Srinivasan ^a   Burikhanov, Ravshan ^b   Akbarsha, Mohammed A ^c   Chendil, Damodaran ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c BHARATHIDASAN UNIVERSITY   (India)

Author keywords

Anti cancer activity; Apoptosis; Herbal medicine; Lung cancer; Radio sensitisation

Indexed keywords

CASPASE 3; CHLOROFORM; HERBACEOUS AGENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RASAGENTHI LEHYAM EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG RESEARCH; ENZYME ACTIVATION; EPITHELIUM CELL; GENE CONTROL; HUMAN; HUMAN CELL; INDIA; LUNG CANCER; MEDICINAL PLANT; NUCLEAR EXPORT SIGNAL; RADIOSENSITIVITY; RASAGENTHI LEHYAM; TRADITIONAL MEDICINE; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIA; LUNG NEOPLASMS; MEDICINE, HERBAL; MEDICINE, TRADITIONAL; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION TOLERANCE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 29244477567     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-005-8518-3     Document Type: Article

References (37)

1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005 15761078
2. MuFphy SL: Deaths: final data for 1998. Natl Vital Stat Rep 48: 1-105, 2000 10934859
3. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK: The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 88: 2398-2424, 2000
4. ten Bokkel Huinink WW, Bergman B, Chemaissani A, Dornoff W, Drings P, Kellokumpu-Lehtinen PL, Liippo K, Mattson K, von Pawel J, Ricci S, Sederholm C, Stahel RA, Wagenius G, Walree NV, Manegold C: Single-agent gemcitabine: An active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer. Lung Cancer 26: 85-94, 1999 10.1016/ S0169-5002(99)00067-7
5. Sandler AB, Nemunaitis J, Denham C, von Pawel J, Cormier Y, Gatzemeier U, Mattson K, Manegold C, Palmer MC, Gregor A, Nguyen B, Niyikiza C, Einhorn LH: Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 18: 122-130, 2000 10623702
6. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, van Rompay M, Kessler RC: Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 280: 1569-1575, 1998 10.1001/jama.280.18.1569
7. Sadava D, Ahn J, Zhan M, Pang ML, Ding J, Kane SE: Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Chemother Pharmacol 49: 261-266, 2002 10.1007/s00280-002-0427-5
8. Cragg GM, Newman DJM, Snader KM: Natural products in drug discovery and development. J Nat Prod 60: 52-60, 1997 9014353
9. Hu H, Ahn NS, Yang X, Lee YS, Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102: 250-253, 2002 12397644
10. Agarwal C, Singh RP, Agarwal R: Grape seed extract induces apoptotic death of human prostate carcinoma DU145 cells via caspases activation accompanied by dissipation of mitochondrial membrane potential and cytochrome- c release. Carcinogenesis 23: 1869-1876, 2002 12419835
11. Kao ST, Yeh CC, Hsieh CC, Yang MD, Lee MR, Liu HS, Lin JG: The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sci 69: 1485-1496, 2001 10.1016/S0024-3205(01)01226-7
12. Bonham M, Arnold H, Montgomery B, Nelson PS: Molecular effects of the herbal compound PC-SPES: Identification of activity pathways in prostate carcinoma. Cancer Res 62: 3920-3924, 2002 12124319
13. White E: Life, death and the pursuit of apoptosis. Genes Dev 10: 1-15, 1996 8557188
14. StaunBon MJ, Gaffney EF: Apoptosis: basic concepts and potential significance in human cancer. Arch Pathol Lab Med 122: 310-319, 1998 9648897
15. Tanaka H, Arakawa H, Yamaguchi T, Shiraishi K, Fukuda S, Matsui K, Takei Y, Nakamura Y: A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature 404: 42-49, 2000 10716435
16. Vogelstein B, Kinzler KW: P53 Function and dysfunction. Cell 70: 523-526, 1992 10.1016/0092-8674(92)90421-8
17. Levine AJ: P53, The cellular gatekeeper for growth and division. Cell 88: 323-331, 1997 10.1016/S0092-8674(00)81871-1
18. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumour suppressor p53 is a regulator of Bcl-2 and Bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805, 1994 8183579
19. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C, Hickman JA: Bcl-2 modulation of apoptosis induced by anti-cancer drugs: Resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321-3326, 1993 8324744
20. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993 10.1016/0092-8674(93)90508-N
21. Groeger AM, Esposito V, De Luca A, Cassandro R, Tonini G, Ambrogi V, Baldi F, Goldfarb R, Mineo TC, Baldi A, Wolner E: Prognostic value of immunohistochemical expression of p53, Bax, Bcl-2 and Bcl-xL in resected non-small-cell lung cancers. Histopathology 44: 54-63, 2004 10.1111/ j.1365-2559.2004.01750.x
22. Green DR, Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998 9721092
23. Ranga RS, Girija R, Nur EAM, Sathishkumar S, Akbarsha MA, Thirugnanam S, Rohr J, Ahmed MM, Chendil D: Rasagenthi Lehyam (RL) a novel complementary and alternative medicine for prostate cancer. Cancer Chemother Pharmacol 54: 7-15, 2004 10.1007/s00280-004-0770-9
24. Sowmyalakshmi S, Nur EAM, Akbarsha MA, Thirugnanam S, Rohr J, Chendil D: Investigation on Semecarpus Lehyam - a Siddha medicine for breast cancer. Planta 220: 910-918, 2005 10.1007/s00425-004-1405-4
25. Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM: Curcumin confers radio-sensitising effect in prostate cancer cell line PC-3. Oncogene 23: 1599-1607, 2004 10.1038/sj.onc.1207284
26. PKo LJ, Prives C: P53: puzzle and paradigm. Genes Dev 10: 1054-1072, 1996 8654922
27. Hollstein M, Sidransky D, Vogelstein B, Harris CC: P53 Mutations in human cancers. Science 253: 49-53, 1991 1905840
28. Kelloff GJ, Crowell JA, Steele VE, Lubet RA, Malone WA, Boone CW, Kopelovich L, Hawk ET, Lieberman R, Lawrence JA, Ali I, Viner JL, Sigman CC: Progress in cancer chemoprDvention: development of diet-derived chemopreventive agents. J Nutr 130: 467S-471S, 2000 10721931
29. Friesen C, Herr I, Krammer PH, Debatin KM: Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2: 574-577, 1996 10.1038/nm0596-574
30. Brown JM, Wouters BG: Apoptosis, p53 and tumour cell sensitivity to anti-cancer agents. Cancer Res 59: 1391-1399, 1999 10197600
31. Cory S, AdaRs JM: The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2: 647-656, 2002 10.1038/nrc883
32. Kroemer G, Reed JC: Mitochondrial control of cell death. Nat Med 6: 513-519, 2000 10.1038/74994
33. Vieira HL, Haouzi D, El Hamel C, Jacotot E, Belzacq AS, Brenner C, Kroemer G: Permeabilisation of the mitochondrial inner membrane during apoptosis: Impact of the adenine nucleotide translocator. Cell Death Differ 7: 1146-1154, 2000 10.1038/sj.cdd.4400778
34. Chen Q, Gong B, Almasan A: Distinct stages of cytochrome- c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress-induced apoptosis. Cell Death Differ 7: 227-233, 2000 10.1038/sj.cdd.4400629
35. O'Connor PM, Fan SI DNA damage checkpoints: implications for cancer therapy. Prog Cell Cycle Res 2: 165-173, 1996 9552393
36. Demarcq C, Bunch RT, Creswell D, Eastman A: The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells. Cell Growth Differ 5: 983-993, 1994 7819136
37. Jackson JR, Gilmartin A, Imburgia C, Winkler JD, Marshall LA, Roshak A: An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Cancer Res 60: 566-572, 2000 10676638